Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jane Ferraro

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in EuropeJohn A Branda, Franc Strle, Klemen Strle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
A rational approach to the stool ova and parasite examinationJohn A Branda, Tai-Yuan David Lin, Eric S Rosenberg, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2003
Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibilityGeorge Sakoulas, Howard S Gold, Lata Venkataraman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2013
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and AztreonamMichael N Dudley, Paul G Ambrose, Sujata M Bhavnani, et al.
Journal of Clinical Microbiology|November 10, 2006
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter sppRonald N Jones, Mary Jane Ferraro, L Barth Reller, et al.
The Journal of Infectious Diseases|November 26, 2002
Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotypeSatish K Pillai, George Sakoulas, Christine Wennersten, et al.
Journal of Clinical Microbiology|June 6, 2007
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of viewDaniel Curcio, Francisco Fernández, Ronald N Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for AzithromycinEllen N Kersh, Vanessa Allen, Eric Ransom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier testJohn A Branda, Maria E Aguero-Rosenfeld, Mary Jane Ferraro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme DiseaseJohn A Branda, Klemen Strle, Lise E Nigrovic, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in EuropeJohn A Branda, Franc Strle, Klemen Strle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
A rational approach to the stool ova and parasite examinationJohn A Branda, Tai-Yuan David Lin, Eric S Rosenberg, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2003
Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibilityGeorge Sakoulas, Howard S Gold, Lata Venkataraman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2013
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and AztreonamMichael N Dudley, Paul G Ambrose, Sujata M Bhavnani, et al.
Journal of Clinical Microbiology|November 10, 2006
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter sppRonald N Jones, Mary Jane Ferraro, L Barth Reller, et al.
The Journal of Infectious Diseases|November 26, 2002
Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotypeSatish K Pillai, George Sakoulas, Christine Wennersten, et al.
Journal of Clinical Microbiology|June 6, 2007
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of viewDaniel Curcio, Francisco Fernández, Ronald N Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for AzithromycinEllen N Kersh, Vanessa Allen, Eric Ransom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier testJohn A Branda, Maria E Aguero-Rosenfeld, Mary Jane Ferraro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme DiseaseJohn A Branda, Klemen Strle, Lise E Nigrovic, et al.
Pageof 5